Literature DB >> 8384451

The hepatic glucose-6-phosphatase system in Ehrlich-ascites-tumour-bearing mice.

R W Lucius1, I D Waddell, A Burchell, R C Nordlie.   

Abstract

To examine the effects of the presence of Ehrlich ascites tumours on both the catalytic unit and the substrate/product translocase components of the glucose-6-phosphatase system in vivo, we isolated microsomes from the livers of control and tumour-bearing mice. Samples were analysed immunochemically for the quantity of catalytic unit, stabilizing protein and translocases T2 and T3 proteins. In comparison experiments, a variety of kinetic studies were performed. The most striking findings in tumour-bearing mice were: a 2.5-fold increase in the quantity of translocase T2 protein; increases in the Km and Vmax. for glucose 6-phosphate phosphohydrolase; and a decrease in the Km value for carbamoyl phosphate (carbamoyl-P) of carbamoyl-P:glucose phosphotransferase, all with intact microsomes. The percentage latency at Vmax. decreased for PPi phosphohydrolase and for glucose 6-phosphate phosphohydrolase, but was unaffected for carbamoyl-P:glucose phosphotransferase. These observations support a tumour-related increase in translocase T2 capacity in vivo, as it transports Pi from the microsomal lumen to the medium and carbamoyl-P or PPi from the medium to the microsomal lumen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384451      PMCID: PMC1132366          DOI: 10.1042/bj2900907

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Studies of liver glucose 6-phosphatase. III. Solubilization and properties of the enzyme from normal and diabetic rats.

Authors:  H L SEGAL; M E WASHKO
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Analysis of human hepatic microsomal glucose-6-phosphatase in clinical conditions where the T2 pyrophosphate/phosphate transport protein is absent.

Authors:  R C Nordlie; H M Scott; I D Waddell; R Hume; A Burchell
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  Cloning and expression of a hepatic microsomal glucose transport protein. Comparison with liver plasma-membrane glucose-transport protein GLUT 2.

Authors:  I D Waddell; A G Zomerschoe; M W Voice; A Burchell
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

4.  Identification and characterization of a hepatic microsomal glucose transport protein. T3 of the glucose-6-phosphatase system?

Authors:  I D Waddell; H Scott; A Grant; A Burchell
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

Review 5.  The molecular basis of the hepatic microsomal glucose-6-phosphatase system.

Authors:  A Burchell; I D Waddell
Journal:  Biochim Biophys Acta       Date:  1991-04-17

6.  Diagnosis of a novel glycogen storage disease: type 1aSP.

Authors:  A Burchell; I D Waddell
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

7.  Hysteretic behavior of the hepatic microsomal glucose-6-phosphatase system.

Authors:  J D Foster; K L Nelson; K A Sukalski; R W Lucius; R C Nordlie
Journal:  Biochim Biophys Acta       Date:  1991-12-11

Review 8.  The molecular basis of the type 1 glycogen storage diseases.

Authors:  A Burchell
Journal:  Bioessays       Date:  1992-06       Impact factor: 4.345

9.  Permeability of rat liver microsomal membrane to glucose 6-phosphate.

Authors:  R Fulceri; G Bellomo; A Gamberucci; H M Scott; A Burchell; A Benedetti
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

10.  The energy state of tumor-bearing rats.

Authors:  J M Argilés; F J López-Soriano
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

View more
  4 in total

1.  Histone II-A stimulates glucose-6-phosphatase and reveals mannose-6-phosphatase activities without permeabilization of liver microsomes.

Authors:  J F St-Denis; B Annabi; H Khoury; G van de Werve
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

2.  Multiple transport protein defects in a patient with glycogen storage disease type 1: GSD 1b/1c beta.

Authors:  R A Hawkins; K R Kamath; H M Scott; A Burchell
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  The human embryonic-fetal kidney endoplasmic reticulum phosphate-pyrophosphate transport protein.

Authors:  R Hume; H Brewerton; A Burchell
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

4.  An altered T2 beta translocase of the glucose-6-phosphatase system in the membrane of the endoplasmic reticulum from livers of Ehrlich-ascites-tumour-bearing mice.

Authors:  R W Lucius; I D Waddell; A Burchell; R C Nordlie
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.